Meningitis Prevention - Most Recent Developments
Meningitis Prevention – Most Recent Developments is a Continuing Professional Development (CPD) course designed for healthcare professionals working in primary care, paediatrics, nursing, pharmacy, immunisation clinics, emergency care, public health, and community healthcare settings. The course provides an evidence-based overview of meningitis epidemiology, vaccination strategies, national immunisation recommendations, and recent developments in meningococcal disease prevention. Meningitis is a serious and potentially life-threatening inflammation of the meninges, commonly caused by bacterial or viral infections. Invasive meningococcal disease can progress rapidly and may result in severe complications including sepsis, neurological injury, hearing loss, limb loss, and death. Despite advances in vaccination programs, meningitis continues to present significant public health challenges worldwide.
.jpg)
Learning Outcomes
What you'll learn
- Explore the changing epidemiology of meningitis and invasive meningococcal disease.
- Recognise the major causative organisms and high-risk populations associated with meningitis.
- Understand current meningitis prevention methods including vaccination programs.
- Identify vaccines available through the National Immunisation Program (NIP), state-funded programs, and private vaccination pathways.
- Understand ATAGI recommendations regarding MenB and MenACWY vaccination.
- Explain the infant 2+1 vaccination schedule and vaccine timing recommendations.
- Recognise early signs and complications of meningitis requiring urgent referral.
- Apply evidence-based patient education and immunisation advocacy strategies.
Stay updated with our
Learning Outcomes
What you'll learn
- Explore the changing epidemiology of meningitis and invasive meningococcal disease.
- Recognise the major causative organisms and high-risk populations associated with meningitis.
- Understand current meningitis prevention methods including vaccination programs.
- Identify vaccines available through the National Immunisation Program (NIP), state-funded programs, and private vaccination pathways.
- Understand ATAGI recommendations regarding MenB and MenACWY vaccination.
- Explain the infant 2+1 vaccination schedule and vaccine timing recommendations.
- Recognise early signs and complications of meningitis requiring urgent referral.
- Apply evidence-based patient education and immunisation advocacy strategies.
Stay updated with our
Training Overview
- Meningitis and Its Epidemiology
- Risk Factors and Clinical Features
- National Immunisation Program and State Vaccination Initiatives
- MenB and MenACWY Vaccination Recommendations
- Infant Vaccination Schedules and Preventive Strategies
- Patient Education, Public Health, and Future Developments
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
.jpg)
.jpg)
.jpg)
Take Your
Learning Anywhere
Stay on top of your learning with the Care Learning app.
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
Meningitis is inflammation of the membranes surrounding the brain and spinal cord, often caused by infection.
Meningococcal disease can progress rapidly and may lead to sepsis, neurological damage, disability, or death.
MenB and MenACWY vaccines help protect against several meningococcal serogroups.
Infants, adolescents, immunocompromised individuals, and people living in crowded environments are at increased risk.
The 2+1 schedule involves two primary vaccine doses followed by one booster dose.
Rapid recognition and treatment are essential because severe disease may progress within hours.